“Use of Brexucabtagene Autoleucel in the Treatment of Relapsed Refractory Mantle Cell Lymphoma”. Electronic Journal Collection Health, vol. 25, no. 6, June 2025, p. e20837, https://doi.org/10.25248/reas.e20837.2025.